Valuation: LifeVantage Corporation

Market Cap 79.35M 68.93M 64.01M 59.03M 111M 7.58B 113M 758M 297M 3.76B 298M 291M 12.65B P/E 2026 *
15x
P/E 2027 * 16.1x
Enterprise Value 65.8M 57.16M 53.08M 48.95M 92.21M 6.28B 93.88M 628M 246M 3.12B 247M 242M 10.49B EV / Sales 2026 *
0.36x
EV / Sales 2027 * 0.36x
Free-Float
87.97%
Yield 2026 *
-
Yield 2027 * -
1 day-0.94%
1 week+0.32%
Current month+0.80%
1 month+0.80%
3 months+24.55%
6 months+18.68%
Current year+2.11%
1 week 6.2
Extreme 6.2
6.59
1 month 5.82
Extreme 5.82
6.61
Current year 3.9
Extreme 3.9
11.71
1 year 3.9
Extreme 3.9
15
3 years 3.9
Extreme 3.9
27.38
5 years 3.04
Extreme 3.04
27.38
10 years 2.86
Extreme 2.86
27.38
Manager TitleAgeSince
Chief Executive Officer 74 30/04/2026
Director of Finance/CFO 53 25/10/2021
Chief Tech/Sci/R&D Officer - 07/01/2026
Director TitleAgeSince
Director/Board Member 74 01/01/2012
Director/Board Member 67 01/02/2017
Director/Board Member 68 17/02/2022
Date Insider Type Main position Quantity % Market Cap.
7/1/26 A Tax

Chief Financial Officer

-1,361 0.0108%
7/1/26 A Tax

Responsable ventes & marketing

-1,717 0.0136%
7/1/26 A Tax

General Counsel

-1,342 0.0106%
Change 5-day change 1-year change 3-year change Capi.($)
-0.94%+0.32%-50.55%+20.73% 79.35M
-4.55%-2.61%+51.95%+151.91% 1,030B
-3.66%-1.33%+52.95%+46.62% 617B
-2.24%+0.19%+35.97%+70.64% 455B
-2.29%+1.12%+36.13%+31.18% 350B
-2.28%-0.69%+33.42%+40.48% 299B
-3.15%+0.25%+10.63%+15.03% 265B
-2.12%+3.31%+1.82%-37.38% 225B
0.00%+4.34%+28.63%+64.00% 209B
-1.09%+0.32%+14.40%+70.80% 163B
Average -1.74%+4.35%+21.53%+47.40% 361.27B
Weighted average by Cap. -1.63%+4.87%+37.84%+72.19%

Financials

2026 *2027 *
Net sales 184M 160M 149M 137M 258M 17.58B 263M 1.76B 689M 8.73B 692M 677M 29.37B 178M 155M 144M 133M 250M 17.03B 254M 1.7B 667M 8.46B 670M 655M 28.44B
Net income 5.3M 4.6M 4.27M 3.94M 7.43M 506M 7.56M 50.61M 19.82M 251M 19.9M 19.47M 845M 4.9M 4.26M 3.95M 3.65M 6.87M 468M 6.99M 46.79M 18.32M 232M 18.4M 18M 781M
Net Debt -13.55M -11.77M -10.93M -10.08M -18.99M -1.29B -19.33M -129M -50.66M -642M -50.88M -49.77M -2.16B -15M -13.02M -12.09M -11.15M -21.01M -1.43B -21.39M -143M -56.06M -711M -56.31M -55.08M -2.39B
Logo LifeVantage Corporation
LifeVantage Corporation is an activation company, which is engage in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, weight management products, pre- and pro-biotics, skin and hair care products, and nootropics. The Company’s line of scientifically validated activators includes the flagship Protandim family of products, TrueScience Liquid Collagen, the newest MindBody GLP-1 System, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System , as well as AXIO nootropic energy drink mixes, the full TrueScience line of skin and hair care products, and Petandim, a pet supplement formulated to combat oxidative stress in dogs. It sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand and Singapore.
Employees
235
Date Price Change Volume
30/07/26 $6.290 -0.94% 42,860
29/07/26 $6.350 -1.24% 67,183
28/07/26 $6.430 +0.94% 77,842
27/07/26 $6.370 -2.45% 75,142
24/07/26 $6.530 +4.15% 57,611
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
6.290USD
Average target price
7.000USD
Spread / Average Target
+11.29%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LFVN Stock